Vaccination with MCP-1 cDNA transfectant on human malignant glioma in nude mice induces migration of monocytes and NK cells to the tumor

International Immunopharmacology

Volumn 1, Issue 4, 2001, Pages 657-664

  Nagai, Mutsumi ^a   Masuzawa, Toshio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

MCP 1; Monocyte; NK cell; Tumor vaccine

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; DNA TRANSFECTION; GLIOMA; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MONOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; VACCINATION;

ANIMALS; CANCER VACCINES; CELL MOVEMENT; CHEMOKINE CCL2; G(M1) GANGLIOSIDE; GLIOMA; HUMANS; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MONOCYTES; TRANSFECTION; VACCINATION;

EID: 0035102199     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(00)00050-3     Document Type: Article

References (30)

1. Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity
2. Treatment of established renal cancer by tumor cells engineered to secrete Interleukin-4
3. Vaccinations with tumor cells genetically engineered to produce different cytokines: Effectivity not superior to a classical adjuvant
4. Monocyte chemoattractant protein-1 (MCP-1) gene transduction: An effective tumor vaccine strategy for non-intracranial tumors
5. Irradiated tumor cells adenovirally engineered to secrete granulocyte/macrophage-colony-stimulating factor establish antitumor immunity and eliminate pre-existing tumors in syngeneic mice
6. Interleukin 6 gene transfection into Lewis carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells
7. Murine tumor cells transduced with the gene for tumor necrosis factor
8. Reduced tumorigenicity of murine tumor cells secreting γ-interferon is due to nonspecific host responses and is unrelated to Class 1 major histocompatibility complex expression
9. Retroviral vector-mediated γ-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity
10. Interleukin 12 gene therapy of MHC-negative murine melanoma metastases
11. Cancer immunotherapy of established tumors with IL-12
12. Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration
13. Human tumor vaccines and genetic engineering of tumors with cytokine and histocompatibility genes to enhance immunogenicity
14. Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4
15. Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer
16. Human breast cancer cell line xenografts as models of breast cancer - The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines
17. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line
18. Serologic analysis of the mouse beta chemokine JE/monocyte chemoattractant protein-1
19. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4, or 5, using modified cDNA expression vectors
20. Tankyuno bunri,doutei,jyokyohou
21. Growth of human tumors in immune-deficient scid mice and nude mice
22. A glycolipid on the surface of mouse natural killer cells
23. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy
24. Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis
25. Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas
26. The origin and function of tumor-associated macrophages
27. Macrophages and angiogenesis
28. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
29. Suppression of tumor formation in vivo by expression of the JE gene in malignant cells